About Dr. Jeffrey Braverman
Dr. Braverman is the founder and Medical Director at
Braverman IVF & Reproductive Immunology with offices in Long Island and Manhattan.
Dr. Braverman was honored as the youngest graduate at New York University
where he was accepted at the age of 14. He went on to attend Medical School
at The Mount Sinai Medical Center in Manhattan and completed his internship
and residency at the Albert Einstein School of Medicine in New York.
After completing his residency Dr. Braverman established a private medical
practice in Long Island New York. For more than 25 years, Dr. Braverman
has been treating patients with all complications related to Recurrent
Pregnancy Loss and has become one of the nation's leading authorities
in the field of Reproductive Immunology. He has managed thousands of cycles
of IUI and IVF with a large majority of his patients suffering from Recurrent
Pregnancy Loss . He has consistently maintained one of the highest success
rates despite the complexity of his case load.
Dr. Braverman has gained unequaled experience managing as well as delivering
this High Risk group of patients. In fact Dr. Braverman has delivered
well over 5000 babies in his career. He has been featured with his RPL
autoimmune patients on Discovery Channels Baby Story, local TV news stations,
and has hosted numerous radio shows on reproductive immunology and fertility.
He assists and consults with patients from around the world with problems
related to RPL . He has designed the most complete panel for the diagnosis
and management of immune related pregnancy complications, as well as one
of the most comprehensive thrombophilia (blood clotting) panels available.
His current office staff has all been part of this practice for at least
20 years and most, longer than that. This has also been one of the most
important elements in maintaining our consistency. You will always get
someone knowledgeable when you call the office. Dr. Braverman performs
all his own consults and sonograms. You will never get a "fill in
"when you call for a consult or come in for a visit. He manages every
case from start to finish. . Many of Dr. Braverman's patients from
around the country learn about him in numerous
immunology and fertility chat rooms on the internet, where he has developed a loyal
Dr. Braverman is a member in good standing with the American Society of
Reproductive Immunology, the American Society of Reproductive Medicine,
the European Society of Reproductive Immunology, the American College
of Obstetrics and Gynecology, the New York State Medical Society, the
Nassau County Medical Society and is actively Board Certified from the
American Board of Obstetrics and Gynecology.
Dr. Braverman consults with and has been invited to lecture at many IVF
centers around the world on the topics of reproductive immunology and
recurrent pregnancy loss. He has served as co-chairman of the American
Society of Reproductive Immunology meeting held in New York in 2015.
About Dr. Vidali
Reproductive Surgeon, Reproductive Endocrinologist
Dr. Vidali brings to Braverman IVF & Reproductive Immunology unique
expertise. As a fertility specialist with over 20 years of experience,
Dr. Vidali also has extensive experience in minimally invasive and robotic surgery.
Dr. Vidali specializes in the surgical treatment of endometriosis as it
relates to infertility, implantation failure and pregnancy loss. He has
specific interest in understanding and treating silent endometriosis in
patients with repetitive IVF failure or implantation failure.
He also specializes in non-invasive treatment of uterine fibroids with
laparoscopic myomectomy. In fact, Dr. Vidali pioneered the introduction
of laparoscopic myomectomy for infertility patients, helping to set a
new standard of treatment for women with fibroids who desire fertility1.
Throughout the course of his career Dr. Vidali has held leadership positions
within academics. He was the Director of the Reproductive Endocrinology
and Infertility Division of Hackensack University Medical Center in Hackensack,
NJ, and held two Directorships at Saint Vincent's Catholic Medical
Center in New York City where he was the Director of the Reproductive
Endocrinology and Infertility and the Director of Advanced Laparoscopic Surgery.
After completing his fellowship in Reproductive Endocrinology at Columbia
University, Dr. Vidali embarked on a successful collaboration and partnership
with one of his mentors and laparoscopic surgery and Endometriosis treatment
pioneer Dr. Harry Reich. With Dr. Reich and colleagues, Dr. C.Y. Liu and
Dr. Tamer Seckin, Dr. Vidali partnered to create an advanced gynecologic
surgical practice at St. Vincent's Hospital in New York in 2001.
Dr. Vidali's fellowships include Obstetrics & Gynecology at Georgetown
University and Reproductive Endocrinology and Infertility at Columbia
University College of Physicians & Surgeons.
1: Ribeiro SC, Reich H, Rosenberg J, Guglielminetti E, Vidali A. Laparoscopic
myomectomy and pregnancy outcome in infertile patients. Fertil Steril.
1999 Mar;71(3):571-4. PubMed PMID: 10065802.
About Dr. Gavin Sacks
Dr Gavin Sacks is Clinical Director at IVFAustralia in Sydney, Associate
Professor at the University of New South Wales, and a consultant at both
the Royal Hospital for Women and St George Hospital in Sydney.
Dr. Sacks qualified from the Universities of Cambridge and Oxford in the
UK, and completed his specialist training in Obstetrics and Gynaecology
in London and Sydney. He completed a PhD in reproductive immunology at
the University of Oxford, during which he did some of the earliest studies
on natural killer cells in pregnancy. His publications on the pathogenesis
of preeclampsia from that work are still widely cited. Since then he has
turned his attention to infertility and miscarriage, and has over 40 publications
in reproductive immunology. In particular, he has pioneered natural killer
(NK) cell testing and the ‘Bondi protocol’ immune therapy
in Australia. He has been invited to give lectures and presentations in
countries as diverse as Australia, the UK, India, Vietnam, the Philippines
and Korea. He continues to do basic research through the University of
New South Wales where he is also a lecturer on the MSc in Reproductive
Medicine degree. Dr. Sacks is an Associate Editor for the highly respected
journal Human Reproduction.
Dr. Sacks has always been first and foremost a clinician. His initial research
interest in preeclampsia gave him a unique perspective for a reproductive
medicine specialist, with a strong appreciation of what is required to
achieve a healthy pregnancy. He personally manages over 450 IVF cycles
a year, and also performs fertility procedures such as laparoscopy for
endometriosis, hysteroscopy for adhesions and uterine septum, myomectomy
(removal of fibroids), and testicular sperm extraction. He is particularly
interested in individualised care and the concept of optimising every
aspect of the reproductive pathway. He has been a strong advocate for
PGS (chromosome screening) of embryos in an effort to better understand
the place of immune therapy, and has played a major role in developing
the use of that technology at IVFAustralia.
Dr. Sacks is a subspecialist in reproductive endocrinology and infertility
(UK) and a member of the Fertility Society of Australia, as well as a
Fellow of the Australian and British Royal Colleges of Obstetrics and
Gynaecology. Dr. Sacks’ international experience and academic rigor
further strengthens the team at BRI.
About Dr. Darren Ritsick
Darren Ritsick, Ph.D. joined Braverman IVF & Reproductive Immunology
as Director of Research. Darren and his wife Maggie personally struggled
with recurrent pregnancy loss for more than two years prior to discovering
Dr. Braverman. Happily, under Dr. Braverman's care they quickly achieved
success and were recently blessed with the birth of their beautiful, healthy
and happy baby boy.
Through our interactions with Dr. Ritsick as a patient, it became clear
that he possesses a vast knowledge of reproductive immunology as well
as a sincere passion to help others experiencing the pain and frustration
associated with recurrent pregnancy loss. As Director of Research he will
be involved in helping to further improve and advance our highly personalized
approach to diagnosis and therapy. This will include performing sophisticated
analyses of diagnostic tests and therapeutic approaches currently in use,
as well as helping us to identify, develop and implement the next generation
of diagnostic and therapeutic approaches in reproductive immunology.
Dr. Ritsick received a B.S. in Biology from the University of Richmond,
graduating cum laude with Departmental Honors in Biology. While studying
as an undergraduate, he conducted research on the genetic basis of brain
tumor development and completed an internship at the Center for Immunotherapy
of Cancer and Infectious Diseases at the University of Connecticut Health
Sciences Center. Dr. Ritsick then went on to earn a Ph.D. in Biochemistry,
Cell and Developmental Biology from Emory University for his research
on novel biological roles for reactive oxygen species. His research involved
an interdisciplinary approach including genetics, cell and molecular biology,
and biochemistry. His doctoral work was partially supported by a training
grant from the National Institutes of Health and resulted in six publications
in peer-reviewed journals and presentations at several large scientific
After receiving his Ph.D., Dr. Ritsick served as a Scientific Advisor at
a patent law firm where he participated in various aspects of patent prosecution
in the areas of biotechnology and pharmaceuticals. He worked for a diverse
client base including universities, early stage biotechnology companies,
investors in early stage biotechnology companies, and larger pharmaceutical
companies. A major part of his work was focused on a biotechnology company
developing novel immunomodulatory therapeutics designed to treat autoimmune
diseases and cancer.
Most recently Dr. Ritsick served as Senior Research Project Coordinator
in the Department of Neurosurgery at Emory University where he was involved
in grant preparation and administration and served as coordinator for
the Cancer Cell Biology Program of the Winship Cancer Institute.
About Dr. Nadéra Mansouri-Attia
Dr. Nadéra Mansouri-Attia joined Braverman IVF & Reproductive
Immunology after coming here from France and being educated in the finest
French Universities. She received her MSc. cum Laude in Reproductive Physiology
from University Pierre et Marie Curie, Paris VI, focusing on female reproduction.
She received her Ph.D. summa cum Laude in reproductive Physiology and
Development from University Paris-Sud School's of Medicine, Paris XI.
During her Ph.D., she worked on the bovine model in the context of early
pregnancy. Her research focused on studying the feto-maternal crosstalk
and the impact of Assisted Reproductive Technologies (ART) such as In
Vitro Fertilization-Embryo Transfer (IVF-ET) on the pregnancy outcome
using state-of-the-art technologies to analyze global transcriptomic data.
Her work brought novel insight in the control of embryo implantation and
was the first in the world to raise a very new and important concept in
reproductive medicine, the active role of the endometrium as a biosensor
when confronted to the embryo. The same concept was demonstrated as relevant
and probably also essential in humans only three years ago.
During her post-doctoral training at the University College of Dublin (Ireland),
she gained extraordinary experience in the field of Immunology of Reproduction.
Her work characterized the maternal immune response to early pregnancy
with a particular interest on the fertility issues of the high yielding
This has practical benefits and applications to improve reproduction management
and the use of ART for sterile couples. By screening the early response
of the mother to the embryo and by determining at an early stage the pregnancy
outcome, this work will ultimately lead to the development of new strategies
to counteract the maternal immune response defects. Her work has been
recognized as outstanding and was awarded by the French National Academy
for Agriculture and was published in several top journals in the field
Most recently, she has worked on deciphering the molecular mechanisms and
dysregulation of the ovarian function that could lead to disease such
as ovarian cancer at Baylor College of Medicine (BCM) in Houston. Her
knowledge and use of animal models to study reproductive pathologies will
contribute to the development of future therapies for women.
About Dr. Halit Firat Erden
Dr. Halit Firat Erden leads Braverman IVF & Reproductive Immunology’s
affiliate practice in Istanbul, Turkey. As an affiliate, Dr. Erden works
closely with Dr. Braverman and our entire team to provide patients throughout
the Middle East, Eastern Europe, and Russia with exceptional service and
access to world-renowned treatment.
Dr. Erden is a highly regarded specialist with over 25 years of medical
experience. His specialties and areas of focus include reproductive immunology,
infertility diagnosis and treatment, laparoscopic and hysteroscopic surgery,
and obstetrical, gynaecological, and doppler ultrasonography.
He is member of the American Society of Reproductive Immunology, the European
Society of Human Reproduction, the American Association of Gynecologic
Laparoscopists, the American Society of Reproductive Medicine, and the
Endocrine Society and has published numerous articles and research in
the field. View Dr. Erden’s CV
About Dr. Chan
Dr. Louis Chan is the Director of Hong Kong Reproductive Medicine Centre.
Dr. Louis Chan graduated from the University of Sydney medical school.
Dr Chan became Specialist in Obstetrics and Gynaecology in 2004. Dr Chan
also awarded FRCOG (UK) and Master of Reproductive Medicine (UNSW).
- Master of Reproductive Medicine (UNSW)
- Master of Public Health (CUHK)
- Master of Medical Sciences (HKU)
- Bachelor of Medicine and Bachelor of Surgery (University of Sydney)
- Fellow of Royal College of Obstetricians and Gynaecologists (FRCOG)
- Fellow of Hong Kong College of Obstetricians and Gynaecologists (FHKCOG)
- Fellow of Hong Kong Academy of Medicine (Obstetrics and Gynaecology)
Dr. Chan published more than 60 papers in cited journals, the areas of
publication are as follows:
- Use of diabetic drugs Rosiglitazone to resume ovulation in Chinese patients
with Polycystic Ovarian Syndrome;
- Effects of different drugs (including Ginsenoside Rb1, Rc, and Re, Hypericin,
Rosiglitazone, and non-steroidal anti-inflammatory drugs) on whole rat
embryo development and morphology score;
- Embrytoxicity of hydrosalpingax fluid;
- Expression of divalent metal transporter 1 (DMT1) isoforms in first trimester
human placenta and embryonic tissues;
- Mechanism of Diclofenac induced embryo-toxicity through free oxygen radicals;
- Placental transfer of various drugs (Rosiglitazone, non-steroidal anti-inflammatory
drugs ) in first trimester of human pregnancy
- Treatment of endometrioma by transvaginal aspiration;
- Thyroid dysfunction and pregnancy outcomes;
- Attitude of Chinese patients towards egg and sperm donation;
- Use of Chinese medicine in patients with previous miscarriages and infertility; and
- Perinatal stem cells.
Dr. Chan also written 2 book chapters, one of them entitle 'Newborn
Stem Cells: Identity, Function, and Clinical Potential, in Perinatal Stem Cells.
Suite 1228-30, 12/F, Ocean Centre,
Tsim Sha Tsui, Hong Kong
About Dr. Nikos Prapas and Dr. Yannis Prapas
Dr. Nikos Prapas and Dr. Yannis Prapas are directors of Braverman IVF &
Reproductive Immunology’s Greece affiliate practice, where they
coordinate closely with our team. They perform all procedures at their
state of the art facilities for patients throughout Europe.
Both doctors have earned worldwide recognition for their highly regarded
work in IVF, donor egg cycles, and infertility related surgery. Learn
more about the doctors by
Cassidy Bommer joined Braverman IVF & Reproductive Immunology as a
Clinical Research Assistant in the fall of 2013. Cassidy graduated cum
laude with Honors from Mount Holyoke College with a B.A. in Biological
Sciences and a certificate in Culture, Health, and Science.
Cassidy's interest in reproductive health and pregnancy was sparked
by a high school internship with Lifebank USA, the only company to offer
both cord and placenta blood banking for newborns. She went on to work
as a research assistant in the Reproductive Immunology lab of Dr. Sarah
J. Bacon at Mount Holyoke College, studying the post-mating inflammatory
response during pregnancy in mammals.
During her time as an undergraduate, Cassidy served as a research intern
at University Hospital in Newark, NJ in the Obstetrics & Gynecology
department, assisting in the development of a series of case reports on
the treatment of uterine fibroids during pregnancy. She was also lucky
enough to travel to El Salvador with Basic Health International where
she participated in cervical cancer screenings for women in various low
resource regions of the country.
While studying at Harvard University during her junior year, Cassidy's
essay, "The value of the Darwin & Gender project, addressed to
the National Science Foundation," was selected for publication on
the Darwin Correspondence Project (University of Cambridge) website. Her
senior honors thesis, advised by Mount Holyoke College President Lynn
Pasquerella, addressed models of perinatal support for women in the Massachusetts
criminal justice system. While this work deviated from Cassidy's background
in basic and clinical research, it provided her with a launching point
for her interest in a woman's "right to pregnancy."
Cassidy is excited to be working with Dr. Braverman, Dr. Ritsick, and the
entire team at BRI.
Katie Carlson joined Braverman IVF & Reproductive Immunology as a Clinical
Research Assistant in the summer of 2015. Katie graduated from the University
of Pennsylvania with a B.A. in Biology and a minor in Science, Technology,
During her time as an undergraduate, Katie served as a research assistant
at the University of Tennessee School of Veterinary Medicine, where she
participated in several projects that used animals to learn more about
cancer and cardiovascular disease. Her favorite project was designed to
study the efficacy of Vesicular Stomatitis Virus in treating cancer in dogs.
Katie went on to complete two years of veterinary school at the University
of Pennsylvania, but decided she wanted to get more involved in human
medicine. This experience was valuable as she can apply the knowledge
she gained about medicine and immunology to her position at BRI.
Katie is passionate about science and medicine, and especially educating
people about these subjects. She is excited to be working with the entire
team at BRI, and is thankful for this opportunity to help women make their
dream of becoming mothers a reality.